Orphazyme halves board of directors – chair not up for reelection
.jpg)
Three is the magic number after biotech firm Orphazyme has halved its board of directors, which used to count six people, the firm reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme sells entire business to US biotech company
For subscribers